Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Flexible budgeting adapts to life changes, helping you reallocate resources without derailing your overall plans and savings targets.
21,189 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
After Johnson Johnson released its latest earnings, investors wonder: is this stock a buy? This guide breaks down the...
Jimmy Wales’ Bitcoin bubble call collides with rising on-chain activity and bullish Polymarket bets. Traders see dive...
Publicly traded crypto firms rose 23% in the first half of 2026 while crypto assets declined 36%, widening the gap to...
Southwest Gas missed Q4 earnings by three cents but reaffirmed its 14% annual growth target through 2030, tying the m...
IREN stock fell sharply as investors reprice AI infrastructure bets after a month of steep declines. While the sector...
Global dividend payments in Q3 2025 surged to a record, signaling the largest dividend payout history and fueling ren...
Cardano’s Van Rossem hard fork is set to activate tomorrow, amid a surge in whale buying and rising open interest. Tr...
Biodesix faces a pivotal year in 2025. This guide breaks down the factors shaping biodesix (bdsx) 2025 earnings, the ...
A new paid service promises ultra-fast access to high-profile Truth Social posts, including those from President Trum...
Markets shift from mega-cap tech to overlooked small firms. This story highlights three small-cap ETFs to buy before ...
Firms across tech and logistics are testing cheaper Chinese AI models as U.S. rivals grow pricier. The move spans sta...